Münch group describes coronavirus infection & potential therapies.
SARS-CoV-2 infection profile and therapeutic strategies.
Complementing conventional antibiotics: Frankfurt scientists reveal atomic details for one of Legionella’s enzymatic weapons and develop first inhibitor.
Researchers from IBC2 and BMLS have now made a major step to a better understanding of the genes causing ALS
19 Nov 2020
IBC2 Director @iDikic2 amongst the most influential scientists based on Clarivate’s #HighlyCited2020 list. It's the… https://t.co/89xX2FYf47
29 Oct 2020
Can Father Christmas Travel or Is Christmas Cancelled? IBC2 Director @iDikic2 on itv's Good Morning Britain… https://t.co/H1ff8lxEPK
22 Oct 2020
Proud to announce that the Binder Innovation Prize 2020 goes to IBC2 group leader Christian Münch for his outstandi… https://t.co/yOqLrr6C8Q
07 Sep 2020
Congratulations to the team around @MuenchLab for their groundbreaking work on new therapeutic targets against… https://t.co/MV1AH6ZQma
FOLLOW ON TWITTER